Zhongshan Ophthalmic Center, Sun Yat-sen University
Phase
Observational
Started
2022-08-22
Last updated
2022-09-27
Condition(s) studied
Pediatric Cataract
Study summary
This retrospective-prospective bidirectional cohort study aims to observe ocular parameter changes, different surgical/vision recovery strategies and postoperative adverse effects among young children with cataract. The influence on psychology and cognitive function will be taken into consideration as well.
Eligibility
Sex
ALL
Min age
—
Max age
18 Years
Healthy volunteers
No
Inclusion Criteria:
* aged \< 18 yo at the 1st visit unilateral or bilateral cataract agree to participant in this study and sign the informed consent
Exclusion Criteria:
* adults
Primary outcome measure(s)
Best-corrected visual acuity changes — Baseline and through study completion, an average of 1 year Best-corrected visual acuity changes are measured by visual acuity charts (Teller/Lea symbol/ETDRS chart) every 1 year at scheduled time
Intraocular pressure changes — Baseline and through study completion, an average of 1 year Intraocular pressures are measured by NCT machine
Refractive power changes — Baseline and through study completion, an average of 1 year Refractive power are measured at baseline and every visit at least every 1 year
Ocular biological measurements changes — Baseline and through study completion, an average of 1 year Ocular biological measurements including axial length, corneal keratometry, anterior chamber angle/depth, corneal endothelial cell number and appearance
Incidence changes of postoperative complications — Baseline and through study completion, an average of 1 year Incidence of postoperative complications, such as glaucoma-related adverse, myopic shift, strabismus and anisometropia and so on
Trial sites (1)
Facility
City
Region
Status
Zhongshan Ophthalmic Center
Guangzhou
Guangdong
Recruiting
More Zhongshan Ophthalmic Center, Sun Yat-sen University trials in China
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time on our Cookie Policy page. See also our Privacy Policy.